Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;95:1109-1117
Published online before print November 4, 2004, doi: 10.1161/01.RES.0000150047.16909.ab
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/11/1109    most recent
01.RES.0000150047.16909.abv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molin, D. G.M.
Right arrow Articles by Gittenberger-de Groot, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molin, D. G.M.
Right arrow Articles by Gittenberger-de Groot, A. C.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Developmental biology
Right arrow Genetically altered mice
Right arrow Growth factors/cytokines
Right arrow Other Vascular biology
(Circulation Research. 2004;95:1109.)
© 2004 American Heart Association, Inc.


Integrative Physiology

Transforming Growth Factor ß–SMAD2 Signaling Regulates Aortic Arch Innervation and Development

Daniel G.M. Molin, Robert E. Poelmann, Marco C. DeRuiter, Mohamad Azhar, Thomas Doetschman, Adriana C. Gittenberger-de Groot

From the Department of Anatomy and Embryology (D.G.M.M., R.E.P., M.C.D., A.C.G.-d.G.) Leiden University Medical Center, Leiden, the Netherlands; and the Department of Molecular Genetics, Biochemistry and Microbiology (M.A., T.D.), University of Cincinnati, College of Medicine, Cincinnati, Ohio.

Correspondence to Prof A.C. Gittenberger-de Groot, Department of Anatomy and Embryology, Leiden University Medical Center, PO Box 9602, 2300 RC Leiden, The Netherlands. E-mail acgitten{at}lumc.nl

Aortic arch interruptions in humans and animal models are mainly caused by aberrant development of the fourth pharyngeal arch artery. Little is known about the maturation of this vessel during normal and abnormal development, which is the subject of this study. Tgfß2 knockout mice that present with fourth artery defects have been associated with defective neural crest cell migration. In this study, we concentrated on pharyngeal arch artery development during developmental days 12.5 to 18.5, focusing on neural crest cell migration using a Wnt1-Cre by R26R neural crest cell reporter mouse. Fourth arch artery maturation was studied with antibodies directed against smooth muscle {alpha}-actin and neural NCAM-1 and RMO-270. For diminished transforming growth factor ß (TGF-ß) signaling, SMAD2 and fibronectin have been analyzed. Neural crest migration and differentiation into smooth muscle cells is unaltered in mutants, regardless of the cardiovascular defect found; however, innervation of the fourth arch artery is affected. Absent staining for nuclear SMAD2, NCAM-1, and RMO-270 in the fourth artery in mutant coincides with severe defects of this segment. Likewise, fibronectin expression is diminished in these cases. From these data we conclude the following: (1) neural crest cell migration is not a common denominator in cardiovascular defects of Tgfß2–/– mice; (2) fourth arch artery maturation is a complex process involving innervation; and (3) TGF-ß2 depletion diminishes SMAD2-signaling in the fourth arch artery and coincides with reduced vascular NCAM-1 expression and neural innervation of this artery. We hypothesize that disturbed maturation of the fourth pharyngeal arch artery, and especially abrogated vascular innervation, will result in fourth arch interruptions.


Key Words: vascular innervation • neural crest • NCAM • SMAD • embryo




This article has been cited by other articles:


Home page
DiabetesHome page
P. A.M. Roest, D. G.M. Molin, C. G. Schalkwijk, L. van Iperen, P. Wentzel, U. J. Eriksson, and A. C. Gittenberger-de Groot
Specific Local Cardiovascular Changes of N{varepsilon}-(Carboxymethyl)lysine, Vascular Endothelial Growth Factor, and Smad2 in the Developing Embryos Coincide With Maternal Diabetes-Induced Congenital Heart Defects
Diabetes, May 1, 2009; 58(5): 1222 - 1228.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Hassane, N. Claij, I. S. Lantinga-van Leeuwen, J. C. Van Munsteren, N. Van Lent, R. Hanemaaijer, M. H. Breuning, D. J.M. Peters, and M. C. DeRuiter
Pathogenic Sequence for Dissecting Aneurysm Formation in a Hypomorphic Polycystic Kidney Disease 1 Mouse Model
Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2177 - 2183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Qi, X. Chen, R. E. Gilbert, Y. Zhang, M. Waltham, M. Schache, D. J. Kelly, and C. A. Pollock
High Glucose-Induced Thioredoxin-Interacting Protein in Renal Proximal Tubule Cells Is Independent of Transforming Growth Factor-{beta}1
Am. J. Pathol., September 1, 2007; 171(3): 744 - 754.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Qi, X. Chen, J. Holian, E. Mreich, S. Twigg, R. E. Gilbert, and C. A. Pollock
Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1070 - F1077.
[Abstract] [Full Text] [PDF]